Literature DB >> 17465365

Hydrogel-induced cervicomedullary compression after posterior fossa decompression for Chiari malformation. Case report.

Spiros L Blackburn1, Matthew D Smyth.   

Abstract

The use of an absorbable hydrogel dural sealant has been approved for neurosurgical applications with no published reports of complications to date. The authors present the case of a 13-year-old girl with syringomyelia and quadriparesis who underwent posterior fossa decompression and dural augmentation for Chiari malformation Type I. Dural closure was performed with a dural substitute patch, hydrogel dural sealant, and gelatin sponge. Magnetic resonance imaging, performed after initial postoperative improvement in the patient's quadriparesis deteriorated, demonstrated an expanding epidural mass collection causing cervicomedullary compression. Exploration on postoperative Day 15 revealed an expanded layer of hydrogel underlying a layer of gelatin sponge. The authors conclude that hydrogel dural sealants should be used cautiously in spaces that cannot tolerate significant mass effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465365     DOI: 10.3171/ped.2007.106.4.302

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  Formulation and characterization of poloxamine-based hydrogels as tissue sealants.

Authors:  Eunhee Cho; Jeoung Soo Lee; Ken Webb
Journal:  Acta Biomater       Date:  2012-03-08       Impact factor: 8.947

2.  A highly elastic and adhesive gelatin tissue sealant for gastrointestinal surgery and colon anastomosis.

Authors:  Tony Vuocolo; Roger Haddad; Glenn A Edwards; Russell E Lyons; Nancy E Liyou; Jerome A Werkmeister; John A M Ramshaw; Christopher M Elvin
Journal:  J Gastrointest Surg       Date:  2011-11-12       Impact factor: 3.452

3.  Cauda equina syndrome after a TLIF resulting from postoperative expansion of a hydrogel dural sealant.

Authors:  Brian J Neuman; Kristen Radcliff; Jeffery Rihn
Journal:  Clin Orthop Relat Res       Date:  2012-06       Impact factor: 4.176

Review 4.  Multifunctional Biomedical Adhesives.

Authors:  Rattapol Pinnaratip; Mohammad Saleh Akram Bhuiyan; Kaylee Meyers; Rupak M Rajachar; Bruce P Lee
Journal:  Adv Healthc Mater       Date:  2019-04-03       Impact factor: 9.933

5.  Mechanical characterization of a bifunctional Tetronic hydrogel adhesive for soft tissues.

Authors:  Lindsey Sanders; Roland Stone; Kenneth Webb; Thompson Mefford; Jiro Nagatomi
Journal:  J Biomed Mater Res A       Date:  2014-08-20       Impact factor: 4.396

6.  An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate.

Authors:  Christopher D Pritchard; Timothy M O'Shea; Daniel J Siegwart; Eliezer Calo; Daniel G Anderson; Francis M Reynolds; John A Thomas; Jonathan R Slotkin; Eric J Woodard; Robert Langer
Journal:  Biomaterials       Date:  2010-09-28       Impact factor: 12.479

7.  Mechanically robust, negative-swelling, mussel-inspired tissue adhesives.

Authors:  Devin G Barrett; Grace G Bushnell; Phillip B Messersmith
Journal:  Adv Healthc Mater       Date:  2012-11-23       Impact factor: 9.933

8.  Effectiveness of Repair Techniques for Spinal Dural Tears: A Systematic Review.

Authors:  Elliot H Choi; Alvin Y Chan; Nolan J Brown; Brian V Lien; Ronald Sahyouni; Andrew K Chan; John Roufail; Michael Y Oh
Journal:  World Neurosurg       Date:  2021-02-25       Impact factor: 2.104

9.  Fibrin sealant augmentation with autologous pericranium for duraplasty after suboccipital decompression in Chiari 1 patients: A case series.

Authors:  Fred C Lam; Anirudh Penumaka; Clark C Chen; Edwin G Fischer; Ekkehard M Kasper
Journal:  Surg Neurol Int       Date:  2013-01-18

Review 10.  Delayed cerebrospinal fluid leak after watertight dural closure with a polyethylene glycol hydrogel dural sealant in posterior fossa surgery: case report.

Authors:  Junya Jito; Naoki Nitta; Kazuhiko Nozaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-12-05       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.